Welcome to our dedicated page for DENTSPLY SIRONA news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on DENTSPLY SIRONA stock.
DENTSPLY SIRONA Inc. (symbol: XRAY) stands as the world’s largest manufacturer of professional dental products and technologies. As a global total solutions provider, Dentsply Sirona empowers dental professionals to offer better, safer, and faster dental care. The company’s extensive portfolio includes leading positions in consumables, equipment, technology, and specialty products. Dentsply Sirona is committed to innovation and quality, reflected in its comprehensive end-to-end solutions offering, which spans well-known and established brands in the industry.
Dentsply Sirona emerged from a merger between Dentsply International and Sirona Dental Systems in 2016. Today, the company manufactures and markets a complete range of dental and oral health products, including dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation.
Recently, Dentsply Sirona has announced enhancements to its DS Core platform, a cloud-based solution supporting dental professionals throughout the entire treatment continuum. The platform now boasts improved patient communication tools, a unified ordering system, and support for additional data formats, making it easier for dental practices to collaborate with labs and service providers.
Financially, Dentsply Sirona maintains a robust presence in the dental industry, with significant revenue generated through third-party distributors and direct sales to labs, offices, and consumers. The company’s ongoing commitment to innovation is further demonstrated by its DS World Las Vegas event, an annual gathering that provides dental professionals with market-leading education, networking opportunities, and exposure to the latest dental technologies.
With its headquarters in Charlotte, North Carolina, Dentsply Sirona continues to shape the future of dentistry, striving to enhance patient care and advance dental practices through its unwavering dedication to quality and innovation. For more information on Dentsply Sirona and its products, visit the official website.
Dentsply Sirona (Nasdaq: XRAY) announced a $150 million accelerated share repurchase (ASR) agreement with Goldman Sachs, aimed at enhancing shareholder value. Under this agreement, the company will initially acquire around 3.1 million shares. The final share count will be determined based on the stock's average price during the ASR's valuation period, with potential adjustments affecting total expenditure. The completion of this ASR is expected by the end of Q2 2023, reflecting Dentsply Sirona's commitment to returning capital to shareholders and optimizing its capital structure.
DENTSPLY SIRONA reported a challenging FY22 with net sales decreasing by 7.3% to $3,922 million, compared to $4,231 million in FY21. The company experienced a net loss of $950 million or ($4.41) per share, significantly down from a net income of $411 million in FY21. Q4 showed a 10.9% drop in net sales to $983 million, with adjusted EPS falling 44.4% to $0.46. For FY23, the outlook suggests net sales between $3.85 billion and $3.95 billion, with adjusted EPS anticipated in the range of $1.80 to $2.00.
Dentsply Sirona (Nasdaq: XRAY) announced a major organizational restructuring plan aimed at boosting operational efficiency and shareholder value. The plan is expected to yield between $200 million and $225 million in annual cost savings over the next 18 months. Key components include an 8%-10% workforce reduction, establishment of five global business units, and an optimized management structure. Additionally, the company anticipates $165 million in non-recurring charges, mainly in 2023, while aiming for adjusted earnings of $3.00 per share by 2026. The restructuring aligns with Dentsply Sirona's strategy to address a challenging external environment while fostering sustainable growth.
Dentsply Sirona, a leading manufacturer of dental products, will host an investor conference call and live webcast on February 28, 2023, at 8:30 am ET. This event aims to discuss the company’s fourth quarter and full year 2022 financial results. Interested participants can find the presentation and register for the call on Dentsply Sirona's Investor Relations website at https://investor.dentsplysirona.com. A replay of the webcast will also be accessible afterward. Dentsply Sirona is headquartered in Charlotte, North Carolina, and is known for its innovative dental technologies.
Dentsply Sirona (Nasdaq: XRAY) presented at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023. The company forecasts net sales exceeding $3.88 billion, surpassing its previous outlook range of $3.85 billion to $3.88 billion. The adjusted EPS for the full year 2022 is anticipated to remain within the prior guidance of $1.90 to $2.00. Presentation materials and webcast details are accessible on the company's investor website.
DENTSPLY SIRONA (Nasdaq: XRAY) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 10:30 am PT (1:30 pm ET). A live audio webcast of the presentation will be accessible via the company's investors section on their website. Dentsply Sirona, headquartered in Charlotte, North Carolina, is the world's largest manufacturer of professional dental products, providing innovative solutions that enhance patient care and safety.
Dentsply Sirona (Nasdaq: XRAY) has declared a quarterly cash dividend of $0.125 per share, translating to an indicated annual rate of $0.50 per share. The dividend will be payable on January 13, 2023, to shareholders on record as of December 30, 2022. This move reflects the company’s commitment to returning value to its shareholders while continuing its longstanding history in the dental industry.
Dentsply Sirona reported third-quarter 2022 net sales of $947 million, down by 8.9% year-over-year, with a GAAP loss of $5.01 per share. Adjusted EPS fell by 31.5% to $0.41. Key factors included foreign currency impacts and macroeconomic headwinds, with organic sales slightly declining by 0.7%. The company initiated a comprehensive review to enhance execution and return to growth. Full-year guidance reflects an expected organic sales decline of approximately 2% and adjusted EPS projected between $1.90 and $2.00.
Dentsply Sirona (Nasdaq: XRAY) announced its participation in two key upcoming healthcare conferences. The first is the Jefferies 13th Annual London Healthcare Conference scheduled for November 17, 2022, at 12:20 pm GMT (7:20 am ET). The second is the Evercore ISI 5th Annual HealthCONx Conference on December 1, 2022, at 1:00 pm ET. Interested investors can access live webcasts of these presentations via the Dentsply Sirona website. As the world's largest manufacturer of dental products, Dentsply Sirona focuses on innovative solutions for patient care.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on November 14, 2022, at 8:30 am ET to discuss its third quarter financial results. Investors can access a presentation on the Company's website at this link. To participate in the call, registration is required via this page. A replay of the conference call will also be available online.
As the largest manufacturer of dental products, Dentsply Sirona focuses on advancing patient care through innovative solutions.
FAQ
What is the current stock price of DENTSPLY SIRONA (XRAY)?
What is the market cap of DENTSPLY SIRONA (XRAY)?
What does Dentsply Sirona Inc. do?
What is DS Core?
When was Dentsply Sirona formed?
Where is Dentsply Sirona headquartered?
What event does Dentsply Sirona host annually?
How can I learn more about Dentsply Sirona's products?
What kind of products does Dentsply Sirona offer?
What is the significance of Dentsply Sirona in the dental industry?
How does Dentsply Sirona distribute its products?
What recent updates has Dentsply Sirona announced?
